Xgeva: Side effects, cost, dosage, and more
Bone health in cancer patients: ESMO Clinical Practice Guidelines† - Annals of Oncology
Bone metastases | Nature Reviews Disease Primers
Denosumab More Effective than Zometa® in Patients with Bone Metastases - CancerConnect
Zometa for Preventing Bone Cancer Complications - Clinical Trials Arena
ZOMETA (zoledronic acid) for Hypercalcemia of Malignancy and Bone Metastases - Cancer Therapy Advisor
Effect of denosumab versus zoledronic acid in preventing skeletal-related events in patients with bone metastases by baseline characteristics - ScienceDirect
ZOMETA (zoledronic acid) for Hypercalcemia of Malignancy and Bone Metastases - Cancer Therapy Advisor
Zoledronic acid (Zometa) - Oncology Nurse Advisor
Risk vs. benefit: Bisphosphonates in breast cancer
Differential effect of zoledronic acid on normal trabecular and cortical bone density in oncologic patients with bone metastases - ScienceDirect
Zometa for Preventing Bone Cancer Complications - Clinical Trials Arena
JCM | Free Full-Text | Treatment and Prevention of Bone Metastases from Breast Cancer: A Comprehensive Review of Evidence for Clinical Practice | HTML
ZOMETA (zoledronic acid) for Hypercalcemia of Malignancy and Bone Metastases - Cancer Therapy Advisor
Xgeva (Denosumab) for the Prevention of Metastatic Bone Cancer - Clinical Trials Arena
Modulation of Bone Microenvironment with Zoledronate Enhances the Therapeutic Effects of STI571 and Paclitaxel against Experimental Bone Metastasis of Human Prostate Cancer | Cancer Research
Zoledronic acid to prevent and treat cancer metastasis: new prospects for an old drug | Future Oncology
Efficacy and safety of 12-weekly versus 4-weekly zoledronic acid for prolonged treatment of patients with bone metastases from breast cancer (ZOOM): a phase 3, open-label, randomised, non-inferiority trial - The Lancet Oncology
An interdisciplinary consensus on the management of bone metastases from renal cell carcinoma | Nature Reviews Urology
ZOMETA (zoledronic acid) for Hypercalcemia of Malignancy and Bone Metastases - Cancer Therapy Advisor
Prevention of Bone Metastases in Patients with High-risk Nonmetastatic Prostate Cancer Treated with Zoledronic Acid: Efficacy and Safety Results of the Zometa European Study (ZEUS) - ScienceDirect
Bone Outcomes not Improved when Zometa is Combined with Thalidomide & Interferon - CancerConnect
/iStock-542310846-59fca08dec2f6400374d5607.jpg "Medications for Treating Bone Metastases From Cancer")
Medications for Treating Bone Metastases From Cancer
Less-Frequent Zoledronic Acid in Patients with Bone Metastases - National Cancer Institute
Oestrogen and zoledronic acid driven changes to the bone and immune environments: Potential mechanisms underlying the differential anti-tumour effects of zoledronic acid in pre- and post-menopausal conditions - ScienceDirect
Osteoclast-Targeted Therapy: Bisphosphonates and Denosumab | Oncohema Key
Zometa for Preventing Bone Cancer Complications - Clinical Trials Arena
Treatment of Multiple Myeloma with Bone Metastasis Focus of Study
